Literature DB >> 7569614

[Histopathology of the localized form of cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis].

M A Moraes1, F T Silveira.   

Abstract

The microscopic changes found in the localized form of the human cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis are reported. In this form, less known than the diffuse one caused by the same species, the clinical manifestations are identical to those produced by other Leishmania species of the subgenus Viannia. There is, however, in the localized infection by L. (L.) amazonensis, a peculiar feature, only recently discovered: about 50% of the affected individuals are Montenegro-negatives. The main histologic change observed in the skin sections was the presence of groups of macrophages with a large vacuole in the cytoplasm, containing many amastigotes. The microscopic picture is similar to that found in the diffuse form of the disease, the difference being only quantitative. When in large numbers, the macrophages suffers necrosis, which generally starts at the center of the groups. First, in this process, the membrane of the parasitized cells ruptures, and the amastigotes become free; later, both cells and parasites are destroyed. The picture can be seen either in Montenegro-negative or in Montenegro-positive patients. The macrophages with amastigotes may persist in tissues for as long as 6-7 months, while in the infections due to L. (V.) braziliensis the parasites usually disappear in a few weeks.

Entities:  

Mesh:

Year:  1994        PMID: 7569614     DOI: 10.1590/s0036-46651994000500011

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  1 in total

1.  American tegumentary leishmaniasis: an uncommon clinical and histopathological presentation.

Authors:  Adrilena Lopes Adriano; Paula Azevedo Borges Leal; Marcelle Parente Breckenfeld; Igor dos Santos Costa; Clarisse Almeida; Antônio Renê Diógenes de Sousa
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.